⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited KingdomNasdaqGS

ROIV

Roivant Sciences Ltd.

Healthcare · Biotechnology

41.81USD

+0.3300 (+0.80%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End03/2026
Last Quarter End06/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 41.81
P/E—
Dvd Ind Yld—
P/B7.14
P/S4,009.6
Curr EV/T12M EBITDA-20.0
Mkt Cap (USD)30.2B
Curr EV (USD)27.2B
2)

Per Share Data

EPS T12M-0.37
DPS—
Bk Val Per Sh5.86
Rev/Sh0.01
Cash/Sh5.32
Curr Shares Out722.3M
FCF/Sh-1.14
3)

Cash Flow Analysis

P/CF-37.0
Curr P/FCF-36.8
CF/NI3.1
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-10840.0%
Eff Interest Rate10.4%
4)

Growth Potential

Dil EPS 1Y Gr-125.0%
Cap 1Y Gr-3.4%
BPS 1Y Gr1.0%
R&D To Sales9704.0%
Retention Rate100.0%
Rev 1Y Gr-71.6%
FCF 1Y Gr10.1%
Assets 1Y Gr5.0%
5)

Profitability

EBITDA-0.6B
EBIT-0.6B
Operating Margin-7914.8%
Pretax Margin-3848.6%
Net Margin-3535.0%
ROA-5.2%
ROE-6.2%
ROC—
Asset Turnover0.00
6)

Structure

Current Ratio16.72
Quick Ratio13.62
Debt/Assets6.1%
Debt/Com Eq7.7%
Net Debt/EBITDA1.56
Tot Debt/Capital7.1%
Gross Margin0.0%
EBIT/Int Exp-15.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.